nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—XDH—Azathioprine—multiple sclerosis	0.42	0.8	CbGbCtD
L-Carnitine—SLCO1B1—Methotrexate—multiple sclerosis	0.0547	0.104	CbGbCtD
L-Carnitine—SLC22A8—Methotrexate—multiple sclerosis	0.0504	0.096	CbGbCtD
L-Carnitine—CES1—Phase I biotransformations, non P450—PON1—multiple sclerosis	0.0115	0.097	CbGpPWpGaD
L-Carnitine—SLC25A29—medulla oblongata—multiple sclerosis	0.00542	0.0381	CbGeAlD
L-Carnitine—SLC25A29—midbrain—multiple sclerosis	0.00495	0.0348	CbGeAlD
L-Carnitine—SLC25A29—spinal cord—multiple sclerosis	0.00483	0.034	CbGeAlD
L-Carnitine—CROT—midbrain—multiple sclerosis	0.00454	0.0319	CbGeAlD
L-Carnitine—CPT2—retina—multiple sclerosis	0.00446	0.0314	CbGeAlD
L-Carnitine—SLC25A20—medulla oblongata—multiple sclerosis	0.00432	0.0304	CbGeAlD
L-Carnitine—CRAT—medulla oblongata—multiple sclerosis	0.00419	0.0295	CbGeAlD
L-Carnitine—SLC25A29—nervous system—multiple sclerosis	0.00407	0.0286	CbGeAlD
L-Carnitine—SLC25A20—midbrain—multiple sclerosis	0.00395	0.0278	CbGeAlD
L-Carnitine—SLC25A29—central nervous system—multiple sclerosis	0.00392	0.0276	CbGeAlD
L-Carnitine—SLC25A20—spinal cord—multiple sclerosis	0.00385	0.0271	CbGeAlD
L-Carnitine—CRAT—midbrain—multiple sclerosis	0.00383	0.027	CbGeAlD
L-Carnitine—SLC25A29—cerebellum—multiple sclerosis	0.00383	0.0269	CbGeAlD
L-Carnitine—CRAT—spinal cord—multiple sclerosis	0.00374	0.0263	CbGeAlD
L-Carnitine—CROT—nervous system—multiple sclerosis	0.00373	0.0263	CbGeAlD
L-Carnitine—CROT—central nervous system—multiple sclerosis	0.00359	0.0253	CbGeAlD
L-Carnitine—CROT—cerebellum—multiple sclerosis	0.00351	0.0247	CbGeAlD
L-Carnitine—CES1—Irinotecan Pathway—BCHE—multiple sclerosis	0.0035	0.0295	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IL23A—multiple sclerosis	0.00344	0.029	CbGpPWpGaD
L-Carnitine—SLC25A20—nervous system—multiple sclerosis	0.00325	0.0228	CbGeAlD
L-Carnitine—CPT2—medulla oblongata—multiple sclerosis	0.00323	0.0227	CbGeAlD
L-Carnitine—CRAT—nervous system—multiple sclerosis	0.00315	0.0222	CbGeAlD
L-Carnitine—SLC25A20—central nervous system—multiple sclerosis	0.00313	0.022	CbGeAlD
L-Carnitine—SLC22A16—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00312	0.0263	CbGpPWpGaD
L-Carnitine—SLC25A29—brain—multiple sclerosis	0.00311	0.0219	CbGeAlD
L-Carnitine—CES1—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00307	0.0259	CbGpPWpGaD
L-Carnitine—SLC25A20—cerebellum—multiple sclerosis	0.00306	0.0215	CbGeAlD
L-Carnitine—CRAT—central nervous system—multiple sclerosis	0.00303	0.0213	CbGeAlD
L-Carnitine—CRAT—cerebellum—multiple sclerosis	0.00297	0.0209	CbGeAlD
L-Carnitine—CPT2—midbrain—multiple sclerosis	0.00295	0.0207	CbGeAlD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00294	0.0247	CbGpPWpGaD
L-Carnitine—CPT2—spinal cord—multiple sclerosis	0.00288	0.0202	CbGeAlD
L-Carnitine—CROT—brain—multiple sclerosis	0.00285	0.0201	CbGeAlD
L-Carnitine—SLC25A20—brain—multiple sclerosis	0.00248	0.0175	CbGeAlD
L-Carnitine—CPT2—nervous system—multiple sclerosis	0.00242	0.017	CbGeAlD
L-Carnitine—CRAT—brain—multiple sclerosis	0.00241	0.0169	CbGeAlD
L-Carnitine—CPT1A—cerebellum—multiple sclerosis	0.0024	0.0169	CbGeAlD
L-Carnitine—CPT2—central nervous system—multiple sclerosis	0.00233	0.0164	CbGeAlD
L-Carnitine—CPT2—cerebellum—multiple sclerosis	0.00228	0.016	CbGeAlD
L-Carnitine—SLC22A16—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00218	0.0184	CbGpPWpGaD
L-Carnitine—CPT1A—brain—multiple sclerosis	0.00195	0.0137	CbGeAlD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00187	0.0158	CbGpPWpGaD
L-Carnitine—CPT2—brain—multiple sclerosis	0.00185	0.013	CbGeAlD
L-Carnitine—Choline—BCHE—multiple sclerosis	0.00171	1	CrCbGaD
L-Carnitine—MPO—IL23-mediated signaling events—STAT4—multiple sclerosis	0.00163	0.0138	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—RRM1—multiple sclerosis	0.00163	0.0137	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IL17A—multiple sclerosis	0.00161	0.0136	CbGpPWpGaD
L-Carnitine—SLCO1B1—Irinotecan Pathway—BCHE—multiple sclerosis	0.0015	0.0126	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IL12B—multiple sclerosis	0.0015	0.0126	CbGpPWpGaD
L-Carnitine—CES1—nervous system—multiple sclerosis	0.00144	0.0101	CbGeAlD
L-Carnitine—MPO—spinal cord—multiple sclerosis	0.00143	0.01	CbGeAlD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00142	0.0119	CbGpPWpGaD
L-Carnitine—CES1—central nervous system—multiple sclerosis	0.00139	0.00975	CbGeAlD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00134	0.0113	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00134	0.0113	CbGpPWpGaD
L-Carnitine—SLC22A5—retina—multiple sclerosis	0.00134	0.00941	CbGeAlD
L-Carnitine—SLC22A4—spinal cord—multiple sclerosis	0.0013	0.00916	CbGeAlD
L-Carnitine—XDH—Nucleotide metabolism—RRM1—multiple sclerosis	0.00125	0.0106	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.00122	0.0103	CbGpPWpGaD
L-Carnitine—MPO—nervous system—multiple sclerosis	0.0012	0.00845	CbGeAlD
L-Carnitine—MPO—central nervous system—multiple sclerosis	0.00116	0.00814	CbGeAlD
L-Carnitine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.00116	0.00973	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00114	0.00961	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00114	0.00961	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00114	0.00961	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00114	0.00961	CbGpPWpGaD
L-Carnitine—CPT2—PPAR Alpha Pathway—MYC—multiple sclerosis	0.00113	0.0095	CbGpPWpGaD
L-Carnitine—CES1—brain—multiple sclerosis	0.0011	0.00774	CbGeAlD
L-Carnitine—SLC22A4—cerebellum—multiple sclerosis	0.00103	0.00726	CbGeAlD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000991	0.00835	CbGpPWpGaD
L-Carnitine—SLC22A5—medulla oblongata—multiple sclerosis	0.000967	0.0068	CbGeAlD
L-Carnitine—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000964	0.00812	CbGpPWpGaD
L-Carnitine—SLC22A8—nervous system—multiple sclerosis	0.000961	0.00676	CbGeAlD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000951	0.00801	CbGpPWpGaD
L-Carnitine—SLC22A8—central nervous system—multiple sclerosis	0.000925	0.00651	CbGeAlD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000924	0.00779	CbGpPWpGaD
L-Carnitine—MPO—brain—multiple sclerosis	0.000919	0.00646	CbGeAlD
L-Carnitine—SLC22A5—midbrain—multiple sclerosis	0.000884	0.00621	CbGeAlD
L-Carnitine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000868	0.00731	CbGpPWpGaD
L-Carnitine—SLC22A5—spinal cord—multiple sclerosis	0.000862	0.00606	CbGeAlD
L-Carnitine—SLCO1B1—Transport of organic anions—ALB—multiple sclerosis	0.000856	0.00721	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—CCL5—multiple sclerosis	0.00085	0.00716	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—SRM—multiple sclerosis	0.000848	0.00714	CbGpPWpGaD
L-Carnitine—SLC22A4—brain—multiple sclerosis	0.000839	0.0059	CbGeAlD
L-Carnitine—CPT1A—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	0.00081	0.00682	CbGpPWpGaD
L-Carnitine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000807	0.0068	CbGpPWpGaD
L-Carnitine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000785	0.00661	CbGpPWpGaD
L-Carnitine—CPT1A—PPAR Alpha Pathway—MYC—multiple sclerosis	0.000782	0.00659	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—CCL2—multiple sclerosis	0.000757	0.00637	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000735	0.00619	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000735	0.00619	CbGpPWpGaD
L-Carnitine—SLC22A8—brain—multiple sclerosis	0.000735	0.00517	CbGeAlD
L-Carnitine—SLC25A20—Metabolism—SRM—multiple sclerosis	0.000721	0.00607	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—SRM—multiple sclerosis	0.000721	0.00607	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000721	0.00607	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—APOE—multiple sclerosis	0.000696	0.00587	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000693	0.00583	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—TYK2—multiple sclerosis	0.000687	0.00579	CbGpPWpGaD
L-Carnitine—SLC22A5—cerebellum—multiple sclerosis	0.000684	0.00481	CbGeAlD
L-Carnitine—MPO—Folate Metabolism—IL4—multiple sclerosis	0.00067	0.00564	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	0.000654	0.00551	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IFNG—multiple sclerosis	0.000643	0.00542	CbGpPWpGaD
L-Carnitine—SLCO1B1—Recycling of bile acids and salts—ALB—multiple sclerosis	0.000634	0.00534	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—CD4—multiple sclerosis	0.000621	0.00523	CbGpPWpGaD
L-Carnitine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000607	0.00511	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CYP24A1—multiple sclerosis	0.000597	0.00503	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CYP27B1—multiple sclerosis	0.000597	0.00503	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—CCL2—multiple sclerosis	0.000585	0.00493	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000584	0.00492	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IL1B—multiple sclerosis	0.000574	0.00483	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IL2—multiple sclerosis	0.000572	0.00482	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00057	0.0048	CbGpPWpGaD
L-Carnitine—Myalgia—Mitoxantrone—multiple sclerosis	0.000555	0.00262	CcSEcCtD
L-Carnitine—SLC22A5—brain—multiple sclerosis	0.000555	0.0039	CbGeAlD
L-Carnitine—Diarrhoea—Cladribine—multiple sclerosis	0.000554	0.00262	CcSEcCtD
L-Carnitine—Anxiety—Mitoxantrone—multiple sclerosis	0.000553	0.00261	CcSEcCtD
L-Carnitine—Arrhythmia—Prednisolone—multiple sclerosis	0.000549	0.00259	CcSEcCtD
L-Carnitine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000549	0.00462	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—GPC5—multiple sclerosis	0.000546	0.0046	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—ALB—multiple sclerosis	0.000545	0.00459	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000539	0.00254	CcSEcCtD
L-Carnitine—Dizziness—Cladribine—multiple sclerosis	0.000536	0.00253	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—ICAM1—multiple sclerosis	0.000532	0.00448	CbGpPWpGaD
L-Carnitine—Infection—Mitoxantrone—multiple sclerosis	0.000529	0.0025	CcSEcCtD
L-Carnitine—Eye disorder—Methylprednisolone—multiple sclerosis	0.000527	0.00249	CcSEcCtD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000525	0.00442	CbGpPWpGaD
L-Carnitine—Abdominal pain—Azathioprine—multiple sclerosis	0.000521	0.00246	CcSEcCtD
L-Carnitine—Body temperature increased—Azathioprine—multiple sclerosis	0.000521	0.00246	CcSEcCtD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000521	0.00439	CbGpPWpGaD
L-Carnitine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00052	0.00245	CcSEcCtD
L-Carnitine—Haemoglobin—Betamethasone—multiple sclerosis	0.000516	0.00243	CcSEcCtD
L-Carnitine—Haemoglobin—Dexamethasone—multiple sclerosis	0.000516	0.00243	CcSEcCtD
L-Carnitine—Vomiting—Cladribine—multiple sclerosis	0.000515	0.00243	CcSEcCtD
L-Carnitine—Haemorrhage—Dexamethasone—multiple sclerosis	0.000513	0.00242	CcSEcCtD
L-Carnitine—Haemorrhage—Betamethasone—multiple sclerosis	0.000513	0.00242	CcSEcCtD
L-Carnitine—Angiopathy—Methylprednisolone—multiple sclerosis	0.000512	0.00242	CcSEcCtD
L-Carnitine—Rash—Cladribine—multiple sclerosis	0.000511	0.00241	CcSEcCtD
L-Carnitine—Dermatitis—Cladribine—multiple sclerosis	0.00051	0.00241	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00051	0.00429	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00051	0.00429	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CYP27B1—multiple sclerosis	0.000508	0.00428	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CYP24A1—multiple sclerosis	0.000508	0.00428	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CYP27B1—multiple sclerosis	0.000508	0.00428	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CYP24A1—multiple sclerosis	0.000508	0.00428	CbGpPWpGaD
L-Carnitine—Weight increased—Prednisone—multiple sclerosis	0.000508	0.0024	CcSEcCtD
L-Carnitine—Anorexia—Mitoxantrone—multiple sclerosis	0.000508	0.0024	CcSEcCtD
L-Carnitine—Headache—Cladribine—multiple sclerosis	0.000507	0.00239	CcSEcCtD
L-Carnitine—Arrhythmia—Triamcinolone—multiple sclerosis	0.000505	0.00238	CcSEcCtD
L-Carnitine—Weight decreased—Prednisone—multiple sclerosis	0.000505	0.00238	CcSEcCtD
L-Carnitine—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000504	0.00238	CcSEcCtD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000504	0.00424	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—IFNG—multiple sclerosis	0.000498	0.00419	CbGpPWpGaD
L-Carnitine—Hypotension—Mitoxantrone—multiple sclerosis	0.000498	0.00235	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000497	0.00418	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000497	0.00418	CbGpPWpGaD
L-Carnitine—Depression—Prednisone—multiple sclerosis	0.000496	0.00234	CcSEcCtD
L-Carnitine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000485	0.00229	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000485	0.00229	CcSEcCtD
L-Carnitine—Dysgeusia—Triamcinolone—multiple sclerosis	0.000482	0.00227	CcSEcCtD
L-Carnitine—Nausea—Cladribine—multiple sclerosis	0.000481	0.00227	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—STAT3—multiple sclerosis	0.000481	0.00405	CbGpPWpGaD
L-Carnitine—Vertigo—Prednisolone—multiple sclerosis	0.000481	0.00227	CcSEcCtD
L-Carnitine—Eye disorder—Betamethasone—multiple sclerosis	0.000479	0.00226	CcSEcCtD
L-Carnitine—Eye disorder—Dexamethasone—multiple sclerosis	0.000479	0.00226	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000478	0.00403	CbGpPWpGaD
L-Carnitine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000478	0.00226	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—CCL2—multiple sclerosis	0.000476	0.00401	CbGpPWpGaD
L-Carnitine—Back pain—Triamcinolone—multiple sclerosis	0.000476	0.00225	CcSEcCtD
L-Carnitine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000475	0.00224	CcSEcCtD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000471	0.00397	CbGpPWpGaD
L-Carnitine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000469	0.00221	CcSEcCtD
L-Carnitine—Angiopathy—Dexamethasone—multiple sclerosis	0.000465	0.0022	CcSEcCtD
L-Carnitine—Angiopathy—Betamethasone—multiple sclerosis	0.000465	0.0022	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—GPC5—multiple sclerosis	0.000465	0.00391	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GPC5—multiple sclerosis	0.000465	0.00391	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—SRM—multiple sclerosis	0.000465	0.00391	CbGpPWpGaD
L-Carnitine—Convulsion—Prednisolone—multiple sclerosis	0.000464	0.00219	CcSEcCtD
L-Carnitine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000463	0.00218	CcSEcCtD
L-Carnitine—Hypertension—Prednisolone—multiple sclerosis	0.000462	0.00218	CcSEcCtD
L-Carnitine—Arrhythmia—Betamethasone—multiple sclerosis	0.000458	0.00216	CcSEcCtD
L-Carnitine—Arrhythmia—Dexamethasone—multiple sclerosis	0.000458	0.00216	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000457	0.00385	CbGpPWpGaD
L-Carnitine—Constipation—Mitoxantrone—multiple sclerosis	0.000455	0.00215	CcSEcCtD
L-Carnitine—Pain—Mitoxantrone—multiple sclerosis	0.000455	0.00215	CcSEcCtD
L-Carnitine—CROT—Metabolism—RRM1—multiple sclerosis	0.000453	0.00381	CbGpPWpGaD
L-Carnitine—Diarrhoea—Azathioprine—multiple sclerosis	0.000451	0.00213	CcSEcCtD
L-Carnitine—Haemoglobin—Prednisone—multiple sclerosis	0.000449	0.00212	CcSEcCtD
L-Carnitine—Haemorrhage—Prednisone—multiple sclerosis	0.000447	0.00211	CcSEcCtD
L-Carnitine—MPO—Vitamin B12 Metabolism—IL1B—multiple sclerosis	0.000444	0.00374	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—ALB—multiple sclerosis	0.000444	0.00374	CbGpPWpGaD
L-Carnitine—Vertigo—Triamcinolone—multiple sclerosis	0.000442	0.00209	CcSEcCtD
L-Carnitine—Vertigo—Methylprednisolone—multiple sclerosis	0.000441	0.00208	CcSEcCtD
L-Carnitine—Dizziness—Azathioprine—multiple sclerosis	0.000436	0.00206	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000435	0.00205	CcSEcCtD
L-Carnitine—Cough—Triamcinolone—multiple sclerosis	0.00043	0.00203	CcSEcCtD
L-Carnitine—Convulsion—Triamcinolone—multiple sclerosis	0.000426	0.00201	CcSEcCtD
L-Carnitine—Tachycardia—Prednisolone—multiple sclerosis	0.000426	0.00201	CcSEcCtD
L-Carnitine—Convulsion—Methylprednisolone—multiple sclerosis	0.000426	0.00201	CcSEcCtD
L-Carnitine—Hypertension—Triamcinolone—multiple sclerosis	0.000425	0.00201	CcSEcCtD
L-Carnitine—Hypertension—Methylprednisolone—multiple sclerosis	0.000424	0.002	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000423	0.00356	CbGpPWpGaD
L-Carnitine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000421	0.00199	CcSEcCtD
L-Carnitine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000421	0.00199	CcSEcCtD
L-Carnitine—Myalgia—Triamcinolone—multiple sclerosis	0.000419	0.00198	CcSEcCtD
L-Carnitine—Vomiting—Azathioprine—multiple sclerosis	0.000419	0.00198	CcSEcCtD
L-Carnitine—Myalgia—Methylprednisolone—multiple sclerosis	0.000418	0.00197	CcSEcCtD
L-Carnitine—Eye disorder—Prednisone—multiple sclerosis	0.000418	0.00197	CcSEcCtD
L-Carnitine—Anxiety—Methylprednisolone—multiple sclerosis	0.000417	0.00197	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—TNF—multiple sclerosis	0.000416	0.00351	CbGpPWpGaD
L-Carnitine—Rash—Azathioprine—multiple sclerosis	0.000415	0.00196	CcSEcCtD
L-Carnitine—Dermatitis—Azathioprine—multiple sclerosis	0.000415	0.00196	CcSEcCtD
L-Carnitine—Depression—Methotrexate—multiple sclerosis	0.000415	0.00196	CcSEcCtD
L-Carnitine—Headache—Azathioprine—multiple sclerosis	0.000413	0.00195	CcSEcCtD
L-Carnitine—Renal failure—Methotrexate—multiple sclerosis	0.000409	0.00193	CcSEcCtD
L-Carnitine—Angiopathy—Prednisone—multiple sclerosis	0.000405	0.00191	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—IFNG—multiple sclerosis	0.000405	0.00341	CbGpPWpGaD
L-Carnitine—Vertigo—Betamethasone—multiple sclerosis	0.000401	0.00189	CcSEcCtD
L-Carnitine—Vertigo—Dexamethasone—multiple sclerosis	0.000401	0.00189	CcSEcCtD
L-Carnitine—Arrhythmia—Prednisone—multiple sclerosis	0.000399	0.00188	CcSEcCtD
L-Carnitine—Infection—Triamcinolone—multiple sclerosis	0.000399	0.00188	CcSEcCtD
L-Carnitine—Infection—Methylprednisolone—multiple sclerosis	0.000398	0.00188	CcSEcCtD
L-Carnitine—Insomnia—Prednisolone—multiple sclerosis	0.000395	0.00186	CcSEcCtD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000395	0.00332	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000392	0.00185	CcSEcCtD
L-Carnitine—Paraesthesia—Prednisolone—multiple sclerosis	0.000392	0.00185	CcSEcCtD
L-Carnitine—Tachycardia—Triamcinolone—multiple sclerosis	0.000392	0.00185	CcSEcCtD
L-Carnitine—Nausea—Azathioprine—multiple sclerosis	0.000391	0.00185	CcSEcCtD
L-Carnitine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000391	0.00185	CcSEcCtD
L-Carnitine—Convulsion—Dexamethasone—multiple sclerosis	0.000387	0.00183	CcSEcCtD
L-Carnitine—Convulsion—Betamethasone—multiple sclerosis	0.000387	0.00183	CcSEcCtD
L-Carnitine—Hypertension—Betamethasone—multiple sclerosis	0.000386	0.00182	CcSEcCtD
L-Carnitine—Hypertension—Dexamethasone—multiple sclerosis	0.000386	0.00182	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—RRM1—multiple sclerosis	0.000385	0.00324	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—RRM1—multiple sclerosis	0.000385	0.00324	CbGpPWpGaD
L-Carnitine—Asthenia—Mitoxantrone—multiple sclerosis	0.000382	0.0018	CcSEcCtD
L-Carnitine—Myalgia—Dexamethasone—multiple sclerosis	0.00038	0.00179	CcSEcCtD
L-Carnitine—Myalgia—Betamethasone—multiple sclerosis	0.00038	0.00179	CcSEcCtD
L-Carnitine—Anxiety—Betamethasone—multiple sclerosis	0.000379	0.00179	CcSEcCtD
L-Carnitine—Anxiety—Dexamethasone—multiple sclerosis	0.000379	0.00179	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000378	0.00319	CbGpPWpGaD
L-Carnitine—Haemoglobin—Methotrexate—multiple sclerosis	0.000375	0.00177	CcSEcCtD
L-Carnitine—Hypotension—Methylprednisolone—multiple sclerosis	0.000375	0.00177	CcSEcCtD
L-Carnitine—Pain—Prednisolone—multiple sclerosis	0.000374	0.00176	CcSEcCtD
L-Carnitine—Haemorrhage—Methotrexate—multiple sclerosis	0.000373	0.00176	CcSEcCtD
L-Carnitine—Pharyngitis—Methotrexate—multiple sclerosis	0.000371	0.00175	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.00037	0.00311	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000367	0.00309	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000366	0.00173	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000365	0.00172	CcSEcCtD
L-Carnitine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000364	0.00172	CcSEcCtD
L-Carnitine—Insomnia—Triamcinolone—multiple sclerosis	0.000363	0.00171	CcSEcCtD
L-Carnitine—Insomnia—Methylprednisolone—multiple sclerosis	0.000363	0.00171	CcSEcCtD
L-Carnitine—Infection—Dexamethasone—multiple sclerosis	0.000362	0.00171	CcSEcCtD
L-Carnitine—Infection—Betamethasone—multiple sclerosis	0.000362	0.00171	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—IL1B—multiple sclerosis	0.000361	0.00304	CbGpPWpGaD
L-Carnitine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000361	0.0017	CcSEcCtD
L-Carnitine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00036	0.0017	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—IL2—multiple sclerosis	0.00036	0.00303	CbGpPWpGaD
L-Carnitine—Anaemia—Prednisone—multiple sclerosis	0.000359	0.0017	CcSEcCtD
L-Carnitine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000358	0.00169	CcSEcCtD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000358	0.00301	CbGpPWpGaD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000357	0.00301	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000357	0.00301	CbGpPWpGaD
L-Carnitine—Tachycardia—Dexamethasone—multiple sclerosis	0.000356	0.00168	CcSEcCtD
L-Carnitine—Tachycardia—Betamethasone—multiple sclerosis	0.000356	0.00168	CcSEcCtD
L-Carnitine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000354	0.00167	CcSEcCtD
L-Carnitine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000353	0.00167	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000353	0.00297	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000352	0.00296	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000351	0.00296	CbGpPWpGaD
L-Carnitine—Vertigo—Prednisone—multiple sclerosis	0.000349	0.00165	CcSEcCtD
L-Carnitine—Eye disorder—Methotrexate—multiple sclerosis	0.000349	0.00165	CcSEcCtD
L-Carnitine—Anorexia—Dexamethasone—multiple sclerosis	0.000347	0.00164	CcSEcCtD
L-Carnitine—Anorexia—Betamethasone—multiple sclerosis	0.000347	0.00164	CcSEcCtD
L-Carnitine—Pain—Triamcinolone—multiple sclerosis	0.000344	0.00162	CcSEcCtD
L-Carnitine—Hypotension—Betamethasone—multiple sclerosis	0.000341	0.00161	CcSEcCtD
L-Carnitine—Hypotension—Dexamethasone—multiple sclerosis	0.000341	0.00161	CcSEcCtD
L-Carnitine—Angiopathy—Methotrexate—multiple sclerosis	0.000339	0.0016	CcSEcCtD
L-Carnitine—Vomiting—Mitoxantrone—multiple sclerosis	0.000339	0.0016	CcSEcCtD
L-Carnitine—Convulsion—Prednisone—multiple sclerosis	0.000337	0.00159	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—IL6—multiple sclerosis	0.000336	0.00283	CbGpPWpGaD
L-Carnitine—Hypertension—Prednisone—multiple sclerosis	0.000336	0.00158	CcSEcCtD
L-Carnitine—Rash—Mitoxantrone—multiple sclerosis	0.000336	0.00158	CcSEcCtD
L-Carnitine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000335	0.00158	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—FAS—multiple sclerosis	0.000334	0.00281	CbGpPWpGaD
L-Carnitine—Headache—Mitoxantrone—multiple sclerosis	0.000334	0.00157	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000332	0.00157	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000332	0.00157	CcSEcCtD
L-Carnitine—SLCO1B1—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.000332	0.00279	CbGpPWpGaD
L-Carnitine—Myalgia—Prednisone—multiple sclerosis	0.000331	0.00156	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000331	0.00279	CbGpPWpGaD
L-Carnitine—Anxiety—Prednisone—multiple sclerosis	0.00033	0.00156	CcSEcCtD
L-Carnitine—Insomnia—Betamethasone—multiple sclerosis	0.00033	0.00156	CcSEcCtD
L-Carnitine—Insomnia—Dexamethasone—multiple sclerosis	0.00033	0.00156	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000328	0.00155	CcSEcCtD
L-Carnitine—CPT2—Metabolism—CYP24A1—multiple sclerosis	0.000327	0.00276	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYP27B1—multiple sclerosis	0.000327	0.00276	CbGpPWpGaD
L-Carnitine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000327	0.00154	CcSEcCtD
L-Carnitine—Paraesthesia—Betamethasone—multiple sclerosis	0.000327	0.00154	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—CD4—multiple sclerosis	0.000322	0.00272	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—TNF—multiple sclerosis	0.000322	0.00271	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SRM—multiple sclerosis	0.000322	0.00271	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000322	0.00152	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000322	0.00271	CbGpPWpGaD
L-Carnitine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000321	0.00151	CcSEcCtD
L-Carnitine—Dyspepsia—Betamethasone—multiple sclerosis	0.000321	0.00151	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.00032	0.00269	CbGpPWpGaD
L-Carnitine—Dysgeusia—Methotrexate—multiple sclerosis	0.000318	0.0015	CcSEcCtD
L-Carnitine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000318	0.0015	CcSEcCtD
L-Carnitine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000317	0.00267	CbGpPWpGaD
L-Carnitine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000317	0.0015	CcSEcCtD
L-Carnitine—Decreased appetite—Betamethasone—multiple sclerosis	0.000317	0.0015	CcSEcCtD
L-Carnitine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000317	0.0015	CcSEcCtD
L-Carnitine—Nausea—Mitoxantrone—multiple sclerosis	0.000316	0.00149	CcSEcCtD
L-Carnitine—Infection—Prednisone—multiple sclerosis	0.000315	0.00149	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000315	0.00149	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000315	0.00149	CcSEcCtD
L-Carnitine—Back pain—Methotrexate—multiple sclerosis	0.000314	0.00148	CcSEcCtD
L-Carnitine—Pain—Dexamethasone—multiple sclerosis	0.000312	0.00147	CcSEcCtD
L-Carnitine—Pain—Betamethasone—multiple sclerosis	0.000312	0.00147	CcSEcCtD
L-Carnitine—Tachycardia—Prednisone—multiple sclerosis	0.00031	0.00146	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000308	0.0026	CbGpPWpGaD
L-Carnitine—Anorexia—Prednisone—multiple sclerosis	0.000303	0.00143	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000302	0.00254	CbGpPWpGaD
L-Carnitine—Anaemia—Methotrexate—multiple sclerosis	0.0003	0.00142	CcSEcCtD
L-Carnitine—CPT2—Metabolism—GPC5—multiple sclerosis	0.000299	0.00252	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000299	0.00252	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000299	0.00252	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000298	0.00141	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000298	0.00141	CcSEcCtD
L-Carnitine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000296	0.0014	CcSEcCtD
L-Carnitine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000295	0.00139	CcSEcCtD
L-Carnitine—Vertigo—Methotrexate—multiple sclerosis	0.000292	0.00138	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000289	0.00136	CcSEcCtD
L-Carnitine—Dizziness—Prednisolone—multiple sclerosis	0.000289	0.00136	CcSEcCtD
L-Carnitine—Asthenia—Triamcinolone—multiple sclerosis	0.000288	0.00136	CcSEcCtD
L-Carnitine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000288	0.00136	CcSEcCtD
L-Carnitine—Abdominal pain—Betamethasone—multiple sclerosis	0.000288	0.00136	CcSEcCtD
L-Carnitine—Body temperature increased—Betamethasone—multiple sclerosis	0.000288	0.00136	CcSEcCtD
L-Carnitine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000288	0.00136	CcSEcCtD
L-Carnitine—Asthenia—Methylprednisolone—multiple sclerosis	0.000288	0.00136	CcSEcCtD
L-Carnitine—Insomnia—Prednisone—multiple sclerosis	0.000287	0.00135	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000287	0.00242	CbGpPWpGaD
L-Carnitine—Paraesthesia—Prednisone—multiple sclerosis	0.000285	0.00135	CcSEcCtD
L-Carnitine—Pruritus—Triamcinolone—multiple sclerosis	0.000284	0.00134	CcSEcCtD
L-Carnitine—Cough—Methotrexate—multiple sclerosis	0.000284	0.00134	CcSEcCtD
L-Carnitine—Pruritus—Methylprednisolone—multiple sclerosis	0.000284	0.00134	CcSEcCtD
L-Carnitine—Convulsion—Methotrexate—multiple sclerosis	0.000282	0.00133	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000281	0.00237	CbGpPWpGaD
L-Carnitine—Dyspepsia—Prednisone—multiple sclerosis	0.000279	0.00132	CcSEcCtD
L-Carnitine—CES1—E2F transcription factor network—MYC—multiple sclerosis	0.000279	0.00235	CbGpPWpGaD
L-Carnitine—Myalgia—Methotrexate—multiple sclerosis	0.000277	0.00131	CcSEcCtD
L-Carnitine—Chest pain—Methotrexate—multiple sclerosis	0.000277	0.00131	CcSEcCtD
L-Carnitine—Decreased appetite—Prednisone—multiple sclerosis	0.000276	0.0013	CcSEcCtD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000276	0.00232	CbGpPWpGaD
L-Carnitine—Rash—Prednisolone—multiple sclerosis	0.000275	0.0013	CcSEcCtD
L-Carnitine—Dermatitis—Prednisolone—multiple sclerosis	0.000275	0.0013	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000275	0.00232	CbGpPWpGaD
L-Carnitine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000274	0.00129	CcSEcCtD
L-Carnitine—Headache—Prednisolone—multiple sclerosis	0.000274	0.00129	CcSEcCtD
L-Carnitine—Constipation—Prednisone—multiple sclerosis	0.000271	0.00128	CcSEcCtD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000271	0.00228	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000267	0.00225	CbGpPWpGaD
L-Carnitine—Dizziness—Triamcinolone—multiple sclerosis	0.000266	0.00125	CcSEcCtD
L-Carnitine—Dizziness—Methylprednisolone—multiple sclerosis	0.000265	0.00125	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000265	0.00223	CbGpPWpGaD
L-Carnitine—Infection—Methotrexate—multiple sclerosis	0.000264	0.00124	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—TNF—multiple sclerosis	0.000262	0.00221	CbGpPWpGaD
L-Carnitine—Asthenia—Dexamethasone—multiple sclerosis	0.000262	0.00123	CcSEcCtD
L-Carnitine—Asthenia—Betamethasone—multiple sclerosis	0.000262	0.00123	CcSEcCtD
L-Carnitine—CROT—Metabolism—BCHE—multiple sclerosis	0.00026	0.00219	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—IL6—multiple sclerosis	0.00026	0.00219	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00026	0.00122	CcSEcCtD
L-Carnitine—Nausea—Prednisolone—multiple sclerosis	0.000259	0.00122	CcSEcCtD
L-Carnitine—Pruritus—Betamethasone—multiple sclerosis	0.000258	0.00122	CcSEcCtD
L-Carnitine—Pruritus—Dexamethasone—multiple sclerosis	0.000258	0.00122	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000257	0.00216	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000257	0.00216	CbGpPWpGaD
L-Carnitine—Vomiting—Triamcinolone—multiple sclerosis	0.000255	0.00121	CcSEcCtD
L-Carnitine—Vomiting—Methylprednisolone—multiple sclerosis	0.000255	0.0012	CcSEcCtD
L-Carnitine—Rash—Triamcinolone—multiple sclerosis	0.000253	0.0012	CcSEcCtD
L-Carnitine—Dermatitis—Triamcinolone—multiple sclerosis	0.000253	0.00119	CcSEcCtD
L-Carnitine—Anorexia—Methotrexate—multiple sclerosis	0.000253	0.00119	CcSEcCtD
L-Carnitine—Rash—Methylprednisolone—multiple sclerosis	0.000253	0.00119	CcSEcCtD
L-Carnitine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000252	0.00119	CcSEcCtD
L-Carnitine—Headache—Triamcinolone—multiple sclerosis	0.000252	0.00119	CcSEcCtD
L-Carnitine—Headache—Methylprednisolone—multiple sclerosis	0.000251	0.00118	CcSEcCtD
L-Carnitine—Abdominal pain—Prednisone—multiple sclerosis	0.000251	0.00118	CcSEcCtD
L-Carnitine—Body temperature increased—Prednisone—multiple sclerosis	0.000251	0.00118	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000251	0.00211	CbGpPWpGaD
L-Carnitine—Diarrhoea—Betamethasone—multiple sclerosis	0.000249	0.00118	CcSEcCtD
L-Carnitine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000249	0.00118	CcSEcCtD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000249	0.0021	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—RRM1—multiple sclerosis	0.000248	0.00209	CbGpPWpGaD
L-Carnitine—Hypotension—Methotrexate—multiple sclerosis	0.000248	0.00117	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000242	0.00114	CcSEcCtD
L-Carnitine—Dizziness—Dexamethasone—multiple sclerosis	0.000241	0.00114	CcSEcCtD
L-Carnitine—Dizziness—Betamethasone—multiple sclerosis	0.000241	0.00114	CcSEcCtD
L-Carnitine—Insomnia—Methotrexate—multiple sclerosis	0.00024	0.00113	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000239	0.00202	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000239	0.00202	CbGpPWpGaD
L-Carnitine—Nausea—Triamcinolone—multiple sclerosis	0.000239	0.00113	CcSEcCtD
L-Carnitine—Paraesthesia—Methotrexate—multiple sclerosis	0.000238	0.00112	CcSEcCtD
L-Carnitine—Nausea—Methylprednisolone—multiple sclerosis	0.000238	0.00112	CcSEcCtD
L-Carnitine—Dyspnoea—Methotrexate—multiple sclerosis	0.000237	0.00112	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000234	0.00197	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000234	0.00197	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Prednisone—multiple sclerosis	0.000234	0.0011	CcSEcCtD
L-Carnitine—Dyspepsia—Methotrexate—multiple sclerosis	0.000234	0.0011	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—MYC—multiple sclerosis	0.000232	0.00195	CbGpPWpGaD
L-Carnitine—Vomiting—Dexamethasone—multiple sclerosis	0.000232	0.00109	CcSEcCtD
L-Carnitine—Vomiting—Betamethasone—multiple sclerosis	0.000232	0.00109	CcSEcCtD
L-Carnitine—Decreased appetite—Methotrexate—multiple sclerosis	0.000231	0.00109	CcSEcCtD
L-Carnitine—Rash—Betamethasone—multiple sclerosis	0.00023	0.00108	CcSEcCtD
L-Carnitine—Rash—Dexamethasone—multiple sclerosis	0.00023	0.00108	CcSEcCtD
L-Carnitine—Dermatitis—Dexamethasone—multiple sclerosis	0.00023	0.00108	CcSEcCtD
L-Carnitine—Dermatitis—Betamethasone—multiple sclerosis	0.00023	0.00108	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000229	0.00108	CcSEcCtD
L-Carnitine—Headache—Dexamethasone—multiple sclerosis	0.000228	0.00108	CcSEcCtD
L-Carnitine—Headache—Betamethasone—multiple sclerosis	0.000228	0.00108	CcSEcCtD
L-Carnitine—Asthenia—Prednisone—multiple sclerosis	0.000228	0.00107	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—CYP24A1—multiple sclerosis	0.000227	0.00191	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP27B1—multiple sclerosis	0.000227	0.00191	CbGpPWpGaD
L-Carnitine—Pain—Methotrexate—multiple sclerosis	0.000227	0.00107	CcSEcCtD
L-Carnitine—Pruritus—Prednisone—multiple sclerosis	0.000225	0.00106	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000222	0.00187	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—BCHE—multiple sclerosis	0.000221	0.00186	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—BCHE—multiple sclerosis	0.000221	0.00186	CbGpPWpGaD
L-Carnitine—Diarrhoea—Prednisone—multiple sclerosis	0.000217	0.00102	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000217	0.00102	CcSEcCtD
L-Carnitine—Nausea—Dexamethasone—multiple sclerosis	0.000217	0.00102	CcSEcCtD
L-Carnitine—Nausea—Betamethasone—multiple sclerosis	0.000217	0.00102	CcSEcCtD
L-Carnitine—XDH—Metabolism—SRM—multiple sclerosis	0.000213	0.0018	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—IL6—multiple sclerosis	0.000211	0.00178	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000211	0.00178	CbGpPWpGaD
L-Carnitine—Dizziness—Prednisone—multiple sclerosis	0.00021	0.000991	CcSEcCtD
L-Carnitine—Body temperature increased—Methotrexate—multiple sclerosis	0.00021	0.00099	CcSEcCtD
L-Carnitine—Abdominal pain—Methotrexate—multiple sclerosis	0.00021	0.00099	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—TNF—multiple sclerosis	0.000208	0.00175	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GPC5—multiple sclerosis	0.000208	0.00175	CbGpPWpGaD
L-Carnitine—Vomiting—Prednisone—multiple sclerosis	0.000202	0.000952	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000201	0.00169	CbGpPWpGaD
L-Carnitine—Rash—Prednisone—multiple sclerosis	0.0002	0.000945	CcSEcCtD
L-Carnitine—Dermatitis—Prednisone—multiple sclerosis	0.0002	0.000944	CcSEcCtD
L-Carnitine—Headache—Prednisone—multiple sclerosis	0.000199	0.000938	CcSEcCtD
L-Carnitine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000195	0.000922	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000192	0.00162	CbGpPWpGaD
L-Carnitine—Asthenia—Methotrexate—multiple sclerosis	0.00019	0.000898	CcSEcCtD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000189	0.00159	CbGpPWpGaD
L-Carnitine—Nausea—Prednisone—multiple sclerosis	0.000189	0.00089	CcSEcCtD
L-Carnitine—Pruritus—Methotrexate—multiple sclerosis	0.000188	0.000886	CcSEcCtD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000186	0.00157	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—TNF—multiple sclerosis	0.000182	0.00153	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000182	0.00153	CbGpPWpGaD
L-Carnitine—Diarrhoea—Methotrexate—multiple sclerosis	0.000182	0.000857	CcSEcCtD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000181	0.00153	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000181	0.00153	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000178	0.0015	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000178	0.0015	CbGpPWpGaD
L-Carnitine—Dizziness—Methotrexate—multiple sclerosis	0.000175	0.000828	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000174	0.00146	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—RRM1—multiple sclerosis	0.000172	0.00145	CbGpPWpGaD
L-Carnitine—Vomiting—Methotrexate—multiple sclerosis	0.000169	0.000796	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000168	0.00142	CbGpPWpGaD
L-Carnitine—Rash—Methotrexate—multiple sclerosis	0.000167	0.000789	CcSEcCtD
L-Carnitine—Dermatitis—Methotrexate—multiple sclerosis	0.000167	0.000789	CcSEcCtD
L-Carnitine—Headache—Methotrexate—multiple sclerosis	0.000166	0.000784	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000165	0.00139	CbGpPWpGaD
L-Carnitine—CES1—NRF2 pathway—TGFB1—multiple sclerosis	0.00016	0.00135	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000159	0.00133	CbGpPWpGaD
L-Carnitine—Nausea—Methotrexate—multiple sclerosis	0.000158	0.000744	CcSEcCtD
L-Carnitine—CROT—Metabolism—APOE—multiple sclerosis	0.000156	0.00132	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000151	0.00127	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP27B1—multiple sclerosis	0.00015	0.00127	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP24A1—multiple sclerosis	0.00015	0.00127	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000147	0.00124	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000143	0.00121	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—BCHE—multiple sclerosis	0.000142	0.0012	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.00014	0.00118	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.00014	0.00118	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000138	0.00116	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GPC5—multiple sclerosis	0.000137	0.00116	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—POMC—multiple sclerosis	0.000134	0.00113	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000133	0.00112	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—APOE—multiple sclerosis	0.000133	0.00112	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—APOE—multiple sclerosis	0.000133	0.00112	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000132	0.00111	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000127	0.00107	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—ALB—multiple sclerosis	0.000123	0.00103	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000115	0.000965	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—IL6—multiple sclerosis	0.000114	0.000964	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—POMC—multiple sclerosis	0.000114	0.000963	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—POMC—multiple sclerosis	0.000114	0.000963	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—RRM1—multiple sclerosis	0.000114	0.000959	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SRM—multiple sclerosis	0.000112	0.000946	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000109	0.000917	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000104	0.00088	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ALB—multiple sclerosis	0.000104	0.000878	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ALB—multiple sclerosis	0.000104	0.000878	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—ALB—multiple sclerosis	9.93e-05	0.000836	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—BCHE—multiple sclerosis	9.88e-05	0.000832	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.62e-05	0.00081	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	8.98e-05	0.000756	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—APOE—multiple sclerosis	8.57e-05	0.000722	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	7.91e-05	0.000666	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	7.91e-05	0.000666	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.73e-05	0.000651	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—POMC—multiple sclerosis	7.36e-05	0.00062	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GPC5—multiple sclerosis	7.24e-05	0.000609	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	6.82e-05	0.000574	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ALB—multiple sclerosis	6.71e-05	0.000565	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.71e-05	0.000565	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—BCHE—multiple sclerosis	6.54e-05	0.000551	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—RRM1—multiple sclerosis	6e-05	0.000505	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—APOE—multiple sclerosis	5.94e-05	0.0005	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—POMC—multiple sclerosis	5.1e-05	0.00043	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.04e-05	0.000425	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ALB—multiple sclerosis	4.65e-05	0.000392	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.65e-05	0.000392	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.56e-05	0.000384	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4e-05	0.000337	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—APOE—multiple sclerosis	3.94e-05	0.000332	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.64e-05	0.000307	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.46e-05	0.000292	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—BCHE—multiple sclerosis	3.44e-05	0.00029	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—POMC—multiple sclerosis	3.38e-05	0.000285	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ALB—multiple sclerosis	3.08e-05	0.00026	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—APOE—multiple sclerosis	2.07e-05	0.000174	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—POMC—multiple sclerosis	1.78e-05	0.00015	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ALB—multiple sclerosis	1.62e-05	0.000137	CbGpPWpGaD
